Psychoactive substances are natural or synthetic substances that act on the central nervous system and alter mental processes such as mood, perception, cognition, consciousness, and behaviour. These substances may be legally prescribed medications (e.g., pain medications or sedatives), legally available substances such as alcohol or caffeine, or controlled or illicit drugs. Psychoactive substances can be used for medical, social, cultural, or recreational purposes, but some carry risks of misuse, dependence, and health or social harms when used in harmful ways.
Psychoactive Substances
Ecolink Institute opens UTC training in Hindi
Ecolink Institute starts UTC training in Hindi Mangalore: The Mangalore based Ecolink Institute of well-being, an approved training provider of the Colombo Plan has started a special training on “Understanding addiction and its treatment...
New psychoactive substances (NPS) - the Irish situation.
This factsheet summarises information and statistics on new psychoactive substances gathered from recent reports on prevalence, treatment, mortality and legislation in Ireland.
World Drug Report 2022
The 2022 World Drug Report provides a global overview of the supply and demand of opiates, cocaine, cannabis, amphetamine-type stimulants and new psychoactive substances (NPS), as well as their impact on health.
Another Milestone for Kenya: Launch of the National Standard on Management of Persons with Substance Use Disorders
According to the International Standards for the Treatment of Drug Use Disorders (2020), the use of psychoactive drugs or narcotic drugs and psychotropic substances without medical supervision is associated with significant health risks...
New Psychoactive Substances (NPS) Webinar Series
Various NPS have significantly changed the picture of drug use in different countries. They are now very prominent in the drug market. Indeed, many of these substances are intended to circumvent drug laws and are sold as ‘legal’...
Involvement of the ghrelin system in the maintenance and reinstatement of cocaine-motivated behaviors: a role of adrenergic action at peripheral β1 receptors
Abstract Cocaine addiction is a significant medical and public concern. Despite decades of research effort, development of pharmacotherapy for cocaine use disorder remains largely unsuccessful. This may be partially due to insufficient...
New Psychoactive Substances (NPS): Black market and policy of new psychoactive substances in the Asia region
ISSUP Kazakhstan presented the Third Webinar in the Series on New Psychoactive Substances, with a focus on Black market and policy of new psychoactive substances in the Asia region.
New Psychoactive Substances: Reading List
New psychoactive substances (NPS) are a diverse group of substances designed to replicate the effects of substances like cannabis, cocaine and ecstasy.
Project NEPTUNE training modules
In partnership with the Royal College of Psychiatrists, Project NEPTUNE has developed training modules to improve clinical practice in the management of harms resulting from the use of club drugs and novel psychoactive substances. These...
Guidance on the Clinical Management of Acute and Chronic Harms of Club Drugs and Novel Psychoactive Substances
This document provides guidance on the clinical management of harms resulting from acute intoxication and from the harmful and dependent use of club drugs and Novel Psychoactive Substances (NPS). This is an extensive and comprehensive...